)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Shanghai Pharmaceuticals
Shanghai Pharmaceuticals (601607) investor relations material
Shanghai Pharmaceuticals H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary27 Aug, 2026
Executive summary
Revenue for H1 2026 reached RMB 147.47 billion, up 4.15% year-over-year, with industrial and commercial segments both contributing to growth.
Net profit attributable to shareholders was RMB 3.50 billion, down 21.40% year-over-year, mainly due to one-off items; adjusted net profit excluding non-recurring items rose 1.65%.
Operating cash flow was robust at RMB 4.45 billion, up 349.78% year-over-year.
R&D investment totaled RMB 1.05 billion, representing 7.98% of industrial segment sales.
Financial highlights
Gross profit margin remained stable; operating profit was RMB 5.63 billion, down 17.44% year-over-year.
Basic and diluted EPS were RMB 0.95, down 20.83% year-over-year.
Net assets attributable to shareholders increased 3.24% to RMB 78.35 billion.
Cash and cash equivalents at period-end were RMB 32.28 billion.
Non-recurring gains totaled RMB 1.03 billion, mainly from asset disposals and government grants.
Outlook and guidance
The company will focus on quality growth, innovation, and operational efficiency in H2 2026.
Emphasis on R&D, digital transformation, and supply chain upgrades to drive future performance.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shanghai Pharmaceuticals
- Revenue and net profit rose over 6% year-over-year, driven by strong segment growth.601607
Q1 2026 - Net profit surged 25.74% on one-time gains, while adjusted profit declined 5.56% year-over-year.601607H2 2025
- Q3 profit dropped 38% on higher impairments, but YTD revenue and net profit rose on one-time gains.601607Q3 2025
- Revenue up slightly, but net profit declined amid cost pressures; innovation segments strong.601607Q1 2025
- Net profit surged 51.56% on a 1.56% revenue increase, driven by a one-time consolidation gain.601607H1 2025
- Revenue and net profit rose, driven by commercial and CSO sales despite industrial decline.601607Q3 2024
- H1 2024 revenue up 5.14%, net profit up 12.72%, interim dividend proposed.601607H1 2024
- Net profit surged 20.82% on 5.75% revenue growth, with strong cash flow and R&D investment.601607H2 2024
Next Shanghai Pharmaceuticals earnings date
Q3 202628 Oct, 2026
Shanghai Pharmaceuticals
Next Shanghai Pharmaceuticals earnings date
Q3 202628 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage